The FDA has lifted a pause on administering vaccines for the chikungunya virus, which is a mosquito-borne illness currently spreading from China.

lxchiq is a single-dose vaccine and was approved for at-risk adults 18 and up in 2023. However, administrations of the shot to adults ages 60 and older were paused earlier this year after reports of 17 side effects following vaccination — including two deaths.

“Now they’ve decided that they’re just going to go ahead and push it forward,” BlazeTV host Sara Gonzales says, disturbed.

Unlike COVID, the virus isn't transmitted from person to person. However, like COVID, people are now being quarantined in China.

“I’m like, ‘Oh boy, that feels eerily familiar,’” Gonzales says.

Matt Kibbe of “Kibbe on Liberty” couldn’t agree more.

“Even if we

See Full Page